Advertisement

Pigmentary Alterations and Benign Melanocytic Lesions of the Vulva

  • Konstantinos Linos
  • Tien Anh Nguyen Tran
  • Martin A. Sangueza
  • J. Andrew CarlsonEmail author
Chapter

Abstract

Pigment alterations of the vulva are quite common and due to either hypopigmentation or hyperpigmentation caused by a wide range of inflammatory, infectious, and neoplastic disorders. Because of this broad range of etiologies, accurate clinical diagnosis is difficult; therefore, clinicians must have a low threshold for biopsy when the clinical features are ambiguous. In this chapter, we will review the common causes of vulvar disorders of pigmentation

Keywords

Vulva Hyperpigmentation Hypopigmentation Melanosis Vitiligo Melanocytic nevus Melanotic macule Lichen sclerosus Acanthosis nigricans Atypical genital nevus Spitz nevus Blue nevus 

References

  1. 1.
    Szabo G. Quantitative histological investigation on the melanocyte system in the human epidermis. In: Gordon M, editor. Pigment cell biology. New York: Academic; 1959. p. 99–124.Google Scholar
  2. 2.
    Lu S, Slominski A, Yang SE, Sheehan C, Ross J, Carlson JA. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi. J Cutan Pathol. 2010;37 Suppl 1:26–40.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Friedrich Jr EG, Burch K, Bahr JP. The vulvar clinic: an eight-year appraisal. Am J Obstet Gynecol. 1979;135(8):1036–40.PubMedGoogle Scholar
  4. 4.
    Rock B, Hood AF, Rock JA. Prospective study of vulvar nevi. J Am Acad Dermatol. 1990;22(1):104–6.PubMedGoogle Scholar
  5. 5.
    Tovell HM, Young Jr AW. Diseases of vulva. Classification and incidence of 877 patients seen consecutively in vulva clinic. N Y State J Med. 1977;77(6):938–41.PubMedGoogle Scholar
  6. 6.
    Rock B. Pigmented lesions of the vulva. Dermatol Clin. 1992;10(2):361–70.PubMedGoogle Scholar
  7. 7.
    Edwards L. Pigmented vulvar lesions. Dermatol Ther. 2010;23(5):449–57.PubMedGoogle Scholar
  8. 8.
    Blossom J, Altmayer S, Jones DM, Slominski A, Carlson JA. Volar melanotic macules in a gardener: a case report and review of the literature. Am J Dermatopathol. 2008;30(6):612–9.PubMedGoogle Scholar
  9. 9.
    Venkatesan A. Pigmented lesions of the vulva. Dermatol Clin. 2010;28(4):795–805.PubMedGoogle Scholar
  10. 10.
    Shizume K. Thirty-five years of progress in the study of MSH. Yale J Biol Med. 1985;8(6):561–70.Google Scholar
  11. 11.
    Wisernan MCKE. Genital dermatology atlas. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2004.Google Scholar
  12. 12.
    Jackson R. Melanosis of the vulva. J Dermatol Surg Oncol. 1984;10(2):119–21.PubMedGoogle Scholar
  13. 13.
    Sison-Torre EQ, Ackerman AB. Melanosis of the vulva. A clinical simulator of malignant melanoma. Am J Dermatopathol. 1985;7(Suppl):51–60.PubMedGoogle Scholar
  14. 14.
    Rudolph RI. Vulvar melanosis. J Am Acad Dermatol. 1990;23(5 Pt 2):982–4.PubMedGoogle Scholar
  15. 15.
    Estrada R, Kaufman R. Benign vulvar melanosis. J Reprod Med. 1993;38(1):5–8.PubMedGoogle Scholar
  16. 16.
    Barnhill RL, Albert LS, Shama SK, Goldenhersh MA, Rhodes AR, Sober AJ. Genital lentiginosis: a clinical and histopathologic study. J Am Acad Dermatol. 1990;22(3):453–60.PubMedGoogle Scholar
  17. 17.
    Tran TA, Niu G, Tomasello CA, Tran HV, Ross JS, Carlson JA. The spectrum of grossly visible pigmented lesions in the uterine cervix: a prospective study. Int J Gynecol Pathol. 2014;33(1):89–99.PubMedGoogle Scholar
  18. 18.
    Oliveira A, Lobo I, Selores M. Asymptomatic vulvar pigmentation. Clin Exp Dermatol. 2011;36(8):921–2.PubMedGoogle Scholar
  19. 19.
    Veraldi S, Cavicchini S, Benelli C, Gasparini G. Laugier-Hunziker syndrome: a clinical, histopathologic, and ultrastructural study of four cases and review of the literature. J Am Acad Dermatol. 1991;25(4):632–6.PubMedGoogle Scholar
  20. 20.
    El Shabrawi-Caelen L, Soyer HP, Schaeppi H, Cerroni L, Schirren CG, Rudolph C, et al. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol. 2004;50(5):690–4.PubMedGoogle Scholar
  21. 21.
    Schaffer JV, Orlow SJ. Melanocytic proliferations in the setting of vulvar lichen sclerosus: diagnostic considerations. Pediatr Dermatol. 2005;22(3):276–8; author reply 8–9.PubMedGoogle Scholar
  22. 22.
    Carlson JA, Lamb P, Malfetano J, Ambros RA, Mihm Jr MC. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol. 1998;11(9):844–54.PubMedGoogle Scholar
  23. 23.
    Lenane P, Keane CO, Connell BO, Loughlin SO, Powell FC. Genital melanotic macules: clinical, histologic, immunohistochemical, and ultrastructural features. J Am Acad Dermatol. 2000;42(4):640–4.PubMedGoogle Scholar
  24. 24.
    Chapel TA, Taylor RM, Pinkus H. Volar melanotic macules. Int J Dermatol. 1979;18(3):222–5.PubMedGoogle Scholar
  25. 25.
    Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16(1):36–43.PubMedGoogle Scholar
  26. 26.
    Jih DM, Elder DE, Elenitsas R. A histopathologic evaluation of vulvar melanosis. Arch Dermatol. 1999;135(7):857–8.PubMedGoogle Scholar
  27. 27.
    Rohwedder A, Philips B, Malfetano J, Kredentser D, Carlson JA. Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol. 2002;24(3):230–40.PubMedGoogle Scholar
  28. 28.
    Rohwedder A, Slominski A, Wolff M, Kredentser D, Carlson JA. Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma. Am J Dermatopathol. 2007;29(1):13–7.PubMedGoogle Scholar
  29. 29.
    Kacerovska D, Requena L, Carlson JA, Santonja C, Michal M, Bouda J, et al. Pigmented squamous intraepithelial neoplasia of the anogenital area: a histopathological and immunohistochemical study of 64 specimens from 45 patients exploring the mechanisms of pigmentation. Am J Dermatopathol. 2014;36(6):471–7.PubMedGoogle Scholar
  30. 30.
    Kerley SW, Blute ML, Keeney GL. Multifocal malignant melanoma arising in vesicovaginal melanosis. Arch Pathol Lab Med. 1991;115(9):950–2.PubMedGoogle Scholar
  31. 31.
    Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol. 1998;29(9):932–48.PubMedGoogle Scholar
  32. 32.
    Weedon D. Disorders of pigmentation. Weedon’s skin pathology. 3rd ed. London: Churchill Livingstone; 2010. p. 281–99.Google Scholar
  33. 33.
    Reynolds N, Colins C, Kennedy C. Penile melanosis and lichen sclerosus et atrophicus. Eur J Dermatol. 1993;3:41–2.Google Scholar
  34. 34.
    Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol. 2006;142(7):871–6.PubMedGoogle Scholar
  35. 35.
    Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43(5):362–5.PubMedGoogle Scholar
  36. 36.
    Carlson JA, Carlson GD, Murphy M, Rohwedder A. Lichen sclerosus exhibiting histologic signs of lymphedema: an essential factor in the pathogenesis of verruciform xanthoma. Arch Dermatol. 2012;148(2):260–2; author reply 2.PubMedGoogle Scholar
  37. 37.
    Li Q, Leopold K, Carlson JA. Chronic vulvar purpura: persistent pigmented purpuric dermatitis (lichen aureus) of the vulva or plasma cell (Zoon’s) vulvitis? J Cutan Pathol. 2003;30(9):572–6.PubMedGoogle Scholar
  38. 38.
    Denadai R, Souto RM, Auada-Souto MP. Generalized acanthosis nigricans without systemic disease associated. Dermatol Online J. 2013;19(9):19614.PubMedGoogle Scholar
  39. 39.
    Piccolo V, Russo T, Picciocchi R, Errico M, Ametrano O, Moscarella E. Generalized idiopathic benign acanthosis nigricans in childhood. Ann Dermatol. 2013;25(3):375–7.PubMedCentralPubMedGoogle Scholar
  40. 40.
    Grandhe NP, Bhansali A, Dogra S, Kumar B. Acanthosis nigricans: relation with type 2 diabetes mellitus, anthropometric variables, and body mass in Indians. Postgrad Med J. 2005;81(958):541–4.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Weedon D. Miscellaneous conditions Weedon’s skin pathology. 3rd ed. London: Churchill Livingstone; 2010. p. 502–9.Google Scholar
  42. 42.
    Berk DR, Spector EB, Bayliss SJ. Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol. 2007;143(9):1153–6.PubMedGoogle Scholar
  43. 43.
    Brickman WJ, Binns HJ, Jovanovic BD, Kolesky S, Mancini AJ, Metzger BE. Acanthosis nigricans: a common finding in overweight youth. Pediatr Dermatol. 2007;24(6):601–6.PubMedGoogle Scholar
  44. 44.
    Brickman WJ, Huang J, Silverman BL, Metzger BE. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010;156(1):87–92.PubMedGoogle Scholar
  45. 45.
    Pedro S. Letter: drug-induced acanthosis nigricans. N Engl J Med. 1974;291(8):422.PubMedGoogle Scholar
  46. 46.
    Tromovitch TA, Jacobs PH, Kern S. Acanthosis nigricans-like lesions from nicotinic acid. Arch Dermatol. 1964;89:222–3.PubMedGoogle Scholar
  47. 47.
    Talsania N, Harwood CA, Piras D, Cerio R. Paraneoplastic acanthosis nigricans: the importance of exhaustive and repeated malignancy screening. Dermatol Online J. 2010;16(8):8.PubMedGoogle Scholar
  48. 48.
    De Sanctis V, Soliman A, Arsciani A, Timoncini G, Reggiani L, Zucchini A, et al. Acanthosis nigricans in adolescents: a practical approach. Georgian Med News. 2013;222:73–8.PubMedGoogle Scholar
  49. 49.
    Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002;147(6):1096–101.PubMedGoogle Scholar
  50. 50.
    Grasso V, Colombo C, Favalli V, Galderisi A, Rabbone I, Gombos S, et al. Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: is a Bartter-like syndrome a feature of congenital SIR? Acta Diabetol. 2013;50(6):951–7.PubMedGoogle Scholar
  51. 51.
    Grasinger CC, Wild RA, Parker IJ. Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women. Fertil Steril. 1993;59(3):583–6.PubMedGoogle Scholar
  52. 52.
    Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med. 1995;99(2):207–16.PubMedGoogle Scholar
  53. 53.
    Rogers DL. Acanthosis nigricans. Semin Dermatol. 1991;10(3):160–3.PubMedGoogle Scholar
  54. 54.
    Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore). 1968;47(1):33–51.Google Scholar
  55. 55.
    Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901–16; quiz 17-20.PubMedGoogle Scholar
  56. 56.
    Carlson JA, Grabowski R, Mu XC, Del Rosario A, Malfetano J, Slominski A. Possible mechanisms of hypopigmentation in lichen sclerosus. Am J Dermatopathol. 2002;24(2):97–107.PubMedGoogle Scholar
  57. 57.
    Larregue M, Martin J, Bressieux JM, Canuel C, De Giacomoni P, Ramdenee P, et al. Achromies vitiligoides et dermatite atopique grave. A propos de quatre cas. fre. [Vitiligoid achromias and severe atopic dermatitis. Apropos of 4 cases]. Ann Dermatol Venereol. 1985;112(8):589–600.PubMedGoogle Scholar
  58. 58.
    Vachiramon V, Thadanipon K. Postinflammatory hypopigmentation. Clin Exp Dermatol. 2011;36(7):708–14.PubMedGoogle Scholar
  59. 59.
    Handa S, Handa U. Sarcoidosis presenting as cutaneous hypopigmentation [letter; comment]. Int J Dermatol. 1995;34(11):824.PubMedGoogle Scholar
  60. 60.
    Yang CC, Lee JY, Wong TW. Depigmented extramammary Paget’s disease. Br J Dermatol. 2004;151(5):1049–53.PubMedGoogle Scholar
  61. 61.
    Rose PT. Pigmentary disorders. Med Clin North Am. 2009;93(6):1225–39.PubMedGoogle Scholar
  62. 62.
    Njoo MD, Vitiligo WW. Pathogenesis and treatment. Am J Clin Dermatol. 2001;2(3):167–81.PubMedGoogle Scholar
  63. 63.
    van Geel N, Speeckaert R, Melsens E, Toelle SP, Speeckaert M, De Schepper S, et al. The distribution pattern of segmental vitiligo: clues for somatic mosaicism. Br J Dermatol. 2013;168(1):56–64.PubMedGoogle Scholar
  64. 64.
    Mollet I, Ongenae K, Naeyaert JM. Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders. Dermatol Clin. 2007;25(3):363–71, ix.PubMedGoogle Scholar
  65. 65.
    Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun. 2008;10:227–43.PubMedGoogle Scholar
  66. 66.
    Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16(2):90–100.PubMedGoogle Scholar
  67. 67.
    Asawanonda P, Taylor CR. Wood’s light in dermatology. Int J Dermatol. 1999;38(11):801–7.PubMedGoogle Scholar
  68. 68.
    Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol. 1996;148(4):1219–28.PubMedCentralPubMedGoogle Scholar
  69. 69.
    Montes LF, Abulafia J, Wilborn WH, Hyde BM, Montes CM. Value of histopathology in vitiligo. Int J Dermatol. 2003;42(1):57–61.PubMedGoogle Scholar
  70. 70.
    Hunt RD, Orlow SJ, Schaffer JV. Genital melanocytic nevi in children: experience in a pediatric dermatology practice. J Am Acad Dermatol. 2014;70(3):429–34.PubMedGoogle Scholar
  71. 71.
    Christensen WN, Friedman KJ, Woodruff JD, Hood AF. Histologic characteristics of vulvar nevocellular nevi. J Cutan Pathol. 1987;14(2):87–91.PubMedGoogle Scholar
  72. 72.
    Zembowicz A, McCusker M, Chiarelli C, Dei Tos AP, Granter SR, Calonje E, et al. Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol. 2001;23(3):167–75.PubMedGoogle Scholar
  73. 73.
    Fulciniti F, Ascierto PA, Simeone E, Bove P, Losito S, Russo S, et al. Nevoid melanoma of the vagina: report of one case diagnosed on thin layer cytological preparations. CytoJournal. 2007;4:14.PubMedCentralPubMedGoogle Scholar
  74. 74.
    Ribe A. Melanocytic lesions of the genital area with attention given to atypical genital nevi. J Cutan Pathol. 2008;35 Suppl 2:24–7.PubMedGoogle Scholar
  75. 75.
    Yamazhan M, Ertas IE, Kandiloglu G, Ozeren M. Cellular blue nevus of the vulva mimicking Bartholin’s gland abscess in a 15-year-old girl: a case report. Arch Gynecol Obstet. 2012;285(4):1009–11.PubMedGoogle Scholar
  76. 76.
    Spatz A, Zimmermann U, Bachollet B, Pautier P, Michel G, Duvillard P. Malignant blue nevus of the vulva with late ovarian metastasis. Am J Dermatopathol. 1998;20(4):408–12.PubMedGoogle Scholar
  77. 77.
    Rodriguez HA, Ackerman LV. Cellular blue nevus. Clinicopathologic study of forty-five cases. Cancer. 1968;21(3):393–405.PubMedGoogle Scholar
  78. 78.
    Craddock KJ, Bandarchi B, Khalifa MA. Blue nevi of the Mullerian tract: case series and review of the literature. J Low Genit Tract Dis. 2007;11(4):284–9.PubMedGoogle Scholar
  79. 79.
    Zembowicz A, Phadke PA. Blue nevi and variants: an update. Arch Pathol Lab Med. 2011;135(3):327–36.PubMedGoogle Scholar
  80. 80.
    Tran TA, Carlson JA, Basaca PC, Mihm MC. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol. 1998;25(5):252–8.PubMedGoogle Scholar
  81. 81.
    Izquierdo MJ, Pastor MA, Carrasco L, Moreno C, Kutzner H, Sangueza OP, et al. Epithelioid blue naevus of the genital mucosa: report of four cases. Br J Dermatol. 2001;145(3):496–501.PubMedGoogle Scholar
  82. 82.
    Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol. 2004;28(1):31–40.PubMedGoogle Scholar
  83. 83.
    Gavriilidis P, Michalopoulou I, Chatzikakidou K, Nikolaidou A. Pigmented epithelioid melanocytoma: a new concept encompassing animal-type melanoma and epithelioid blue nevus. BMJ Case Rep. 2013; 22 Mar 2013. pii: bcr-2013-008865. doi:  10.1136/bcr-2013-008865
  84. 84.
    Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma (“malignant blue nevus”). Am J Surg Pathol. 2008;32(1):36–44.PubMedGoogle Scholar
  85. 85.
    Requena L, Carlson J. Melanoma arising from blue naevus. In: LeBoit P, Burg G, Weedon D, Sarasin A, editors. WHO classification of tumors: pathology & genetics of skin tumors. Lyon: IARC; 2006. p. 79–82.Google Scholar
  86. 86.
    Cerez-Pham H, Bertrand G, Tigori J, Simard C. Association of a malignant vaginal melanoma with vaginal melanosis and a blue nevus of the cervix. Apropos of a case. Arch Anat Cytol Pathol. 1984;32(1):48–51.PubMedGoogle Scholar
  87. 87.
    Barnhill RL, Cerroni L, Cook M, Elder DE, Kerl H, LeBoit PE, et al. State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol. 2010;17(2):73–90.PubMedGoogle Scholar
  88. 88.
    Gammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J Cutan Pathol. 2011;38(4):335–41.PubMedGoogle Scholar
  89. 89.
    Hantschke M, Mentzel T, Rutten A, Palmedo G, Calonje E, Lazar AJ, et al. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol. 2010;34(2):216–22.PubMedGoogle Scholar
  90. 90.
    Falconieri G, Bacchi CE, Luzar B. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma. Am J Dermatopathol. 2012;34(6):619–25.PubMedGoogle Scholar
  91. 91.
    Spitz S. Melanomas of childhood. Am J Pathol. 1948;24(3):591–609.PubMedCentralPubMedGoogle Scholar
  92. 92.
    Shimek CM, Golitz LE. The golden anniversary of the Spitz nevus. Arch Dermatol. 1999;135(3):333–5.PubMedGoogle Scholar
  93. 93.
    Spatz A, Calonje E, Handfield-Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch Dermatol. 1999;135(3):282–5.PubMedGoogle Scholar
  94. 94.
    Zedek DC, McCalmont TH. Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma. Clin Lab Med. 2011;31(2):311–20.PubMedGoogle Scholar
  95. 95.
    Elder D, Murphy G. Spindle and epithelioid cell melanocytic tumors. In: Elder D, Murphy G, editors. Melanocytic tumors of the skin. Silver Spring: ARP; 2010. p. 83–113.Google Scholar
  96. 96.
    Crowson AN, Magro CM, Mihm MC. Spitz nevus. In: Crowson AN, Magro CM, Mihm MC, editors. The melanocytic proliferations of the skin. New York: Wiley; 2001. p. 121–76.Google Scholar
  97. 97.
    Massi G, LeBoit PE. Spitz nevus. Histological diagnosis of nevi and melanoma. Darmstadt: Steinkopf Verlag; 2004. p. 169–234.Google Scholar
  98. 98.
    Plaza JA, De Stefano D, Suster S, Prieto VG, Kacerovska D, Michal M, et al. Intradermal spitz nevi: a rare subtype of spitz nevi analyzed in a clinicopathologic study of 74 cases. Am J Dermatopathol. 2014;36(4):283–97.PubMedGoogle Scholar
  99. 99.
    Diaz-Cascajo C, Borghi S, Weyers W. Angiomatoid Spitz nevus: a distinct variant of desmoplastic Spitz nevus with prominent vasculature. Am J Dermatopathol. 2000;22(2):135–9.PubMedGoogle Scholar
  100. 100.
    Tetzlaff MT, Xu X, Elder DE, Elenitsas R. Angiomatoid Spitz nevus: a clinicopathological study of six cases and a review of the literature. J Cutan Pathol. 2009;36(4):471–6.PubMedGoogle Scholar
  101. 101.
    Barr RJ, Morales RV, Graham JH. Desmoplastic nevus: a distinct histologic variant of mixed spindle cell and epithelioid cell nevus. Cancer. 1980;46(3):557–64.PubMedGoogle Scholar
  102. 102.
    Mackie RM, Doherty VR. The desmoplastic melanocytic naevus: a distinct histological entity. Histopathology. 1992;20(3):207–11.PubMedGoogle Scholar
  103. 103.
    Clarke B, Essa A, Chetty R. Plexiform spitz nevus. Int J Surg Pathol. 2002;10(1):69–73.PubMedGoogle Scholar
  104. 104.
    Spatz A, Peterse S, Fletcher CD, Barnhill RL. Plexiform spitz nevus: an intradermal spitz nevus with plexiform growth pattern. Am J Dermatopathol. 1999;21(6):542–6.PubMedGoogle Scholar
  105. 105.
    Busam KJ, Barnhill RL. Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol. 1995;19(9):1061–7.PubMedGoogle Scholar
  106. 106.
    Aoyagi S, Sato-Matsumura KC, Akiyama M, Tanimura S, Shibaki H, Shimizu H. Spitz naevus of the glans penis: an unusual location. Acta Derm Venereol. 2004;84(4):324–5.PubMedGoogle Scholar
  107. 107.
    Polat M, Topcuoglu MA, Tahtaci Y, Hapa A, Yilmaz F. Spitz nevus of the genital mucosa. Indian J Dermatol Venereol Leprol. 2009;75(2):167–9.PubMedGoogle Scholar
  108. 108.
    Filippov SV, Kniaz’kin IV, Anichkov NM, Zeziulin PN, Shinkarenko AV, Bykov NM. Nevus Spitz (“iuvenil’nyi” nevus) kozhi polovogo chlena. [Spitz nevus (juvenile nevus) of the penile skin]. Arkh Patol. 2002;64(1):46–8.PubMedGoogle Scholar
  109. 109.
    Monfrecola G, Ianniello S, Donofrio V, DeRosa G. Multiple agminated Spitz nevi of the penis. J Eur Acad Dermatol. 1994;3:189–93.Google Scholar
  110. 110.
    Dawe RS, Wainwright NJ, Evans AT, Lowe JG. Multiple widespread eruptive Spitz naevi. Br J Dermatol. 1998;138(5):872–4.PubMedGoogle Scholar
  111. 111.
    Weedon D, Little JH. Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer. 1977;40(1):217–25.PubMedGoogle Scholar
  112. 112.
    Llamas-Velasco M, Perez-Gonzalez YC, Requena L, Kutzner H. Histopathologic clues for the diagnosis of Wiesner nevus. J Am Acad Dermatol. 2014;70(3):549–54.PubMedGoogle Scholar
  113. 113.
    Gerami P, Cooper C, Bajaj S, Wagner A, Fullen D, Busam K, et al. Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. Am J Surg Pathol. 2013;37(9):1387–94.PubMedGoogle Scholar
  114. 114.
    Yazdan P, Cooper C, Sholl LM, Busam K, Rademaker A, Weitner BB, et al. Comparative analysis of atypical Spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression. Am J Surg Pathol. 2014;38(5):638–45.PubMedGoogle Scholar
  115. 115.
    Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013;37(5):676–84.PubMedGoogle Scholar
  116. 116.
    Yeh I, Mully TW, Wiesner T, Vemula SS, Mirza SA, Sparatta AJ, et al. Ambiguous melanocytic tumors with loss of 3p21. Am J Surg Pathol. 2014;8(8): 1088–95.Google Scholar
  117. 117.
    Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009;33(8):1146–56.PubMedGoogle Scholar
  118. 118.
    Gammon B, Beilfuss B, Guitart J, Gerami P. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol. 2012;36(1):81–8.PubMedGoogle Scholar
  119. 119.
    Gerami P, Li G, Pouryazdanparast P, Blondin B, Beilfuss B, Slenk C, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012;36(6):808–17.PubMedGoogle Scholar
  120. 120.
    Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol. 2010;146(3):273–8.PubMedGoogle Scholar
  121. 121.
    Gerami P, Busam K, Cochran A, Cook MG, Duncan LM, Elder DE, et al. Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol. 2014;38(7):934–40.PubMedGoogle Scholar
  122. 122.
    Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm Jr MC, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30(5):513–20.PubMedGoogle Scholar
  123. 123.
    North JP, Garrido MC, Kolaitis NA, Leboit PE, McCalmont TH, Bastian BC. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. Am J Surg Pathol. 2014;38(6):824–31.PubMedGoogle Scholar
  124. 124.
    Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967–72.PubMedCentralPubMedGoogle Scholar
  125. 125.
    Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999;113(6):1065–9.PubMedGoogle Scholar
  126. 126.
    Busam KJ, Wanna M, Wiesner T. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. JAMA dermatology. 2013;149(3):335–9.PubMedGoogle Scholar
  127. 127.
    Busam KJ, Sung J, Wiesner T, von Deimling A, Jungbluth A. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes. Am J Surg Pathol. 2013;37(2):193–9.PubMedGoogle Scholar
  128. 128.
    Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36(6):818–30.PubMedCentralPubMedGoogle Scholar
  129. 129.
    Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014;5:3116.PubMedCentralPubMedGoogle Scholar
  130. 130.
    Busam KJ, Kutzner H, Cerroni L, Wiesner T. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions. Am J Surg Pathol. 2014;38(7):925–33.PubMedGoogle Scholar
  131. 131.
    Carlson JA, Mu XC, Slominski A, Weismann K, Crowson AN, Malfetano J, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol. 2002;138(1):77–87.PubMedGoogle Scholar
  132. 132.
    Bussen SS. Melanocytic proliferations associated with lichen sclerosus in adolescence. Arch Gynecol Obstet. 2009;280(6):1039–40.PubMedGoogle Scholar
  133. 133.
    Hassanein AM, Mrstik ME, Hardt NS, Morgan LA, Wilkinson EJ. Malignant melanoma associated with lichen sclerosus in the vulva of a 10-year-old. Pediatr Dermatol. 2004;21(4):473–6.PubMedGoogle Scholar
  134. 134.
    Pinto A, McLaren SH, Poppas DP, Magro CM. Genital melanocytic nevus arising in a background of lichen sclerosus in a 7-year-old female: the diagnostic pitfall with malignant melanoma. A literature review. Am J Dermatopathol. 2012;34(8):838–43.PubMedGoogle Scholar
  135. 135.
    Rosamilia LL, Schwartz JL, Lowe L, Gruber SB, Quint EH, Johnson TM, et al. Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus. J Am Acad Dermatol. 2006;54 Suppl 2:S52–3.PubMedGoogle Scholar
  136. 136.
    Friedman RJ, Kopf AW, Jones WB. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. Am J Dermatopathol. 1984;6(Suppl):253–6.PubMedGoogle Scholar
  137. 137.
    Egan CA, Bradley RR, Logsdon VK, Summers BK, Hunter GR, Vanderhooft SL. Vulvar melanoma in childhood. Arch Dermatol. 1997;133(3):345–8.PubMedGoogle Scholar
  138. 138.
    Clark Jr WH, Hood AF, Tucker MA, Jampel RM. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol. 1998;29(1 Suppl 1):S1–24.PubMedGoogle Scholar
  139. 139.
    Friedman RJ, Ackerman AB. Difficulties in the histologic diagnosis of melanocytic nevi on the vulvae of premenopausal women. In:Ackerman AB, ed. Pathology of Malignant Melanoma. New York, NY:Masson;1981:119:127.Google Scholar
  140. 140.
    Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol. 2006;19 Suppl 2:S4–20.PubMedGoogle Scholar
  141. 141.
    Gleason BC, Hirsch MS, Nucci MR, Schmidt BA, Zembowicz A, Mihm Jr MC, et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008;32(1):51–7.PubMedGoogle Scholar
  142. 142.
    Brenn T. Atypical genital nevus. Arch Pathol Lab Med. 2011;135(3):317–20.PubMedGoogle Scholar
  143. 143.
    Blickstein I, Feldberg E, Dgani R, Ben-Hur H, Czernobilsky B. Dysplastic vulvar nevi. Obstet Gynecol. 1991;78(5 Pt 2):968–70.PubMedGoogle Scholar
  144. 144.
    McCluggage WG. Premalignant lesions of the lower female genital tract: cervix, vagina and vulva. Pathology. 2013;45(3):214–28.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Konstantinos Linos
    • 1
  • Tien Anh Nguyen Tran
    • 2
  • Martin A. Sangueza
    • 3
  • J. Andrew Carlson
    • 4
    Email author
  1. 1.Department of Pathology, Dartmouth-Hitchcock Medical CenterGeisel School of Medicine at DartmouthLebanonUSA
  2. 2.Department of PathologyFlorida Hospital OrlandoOrlandoUSA
  3. 3.Department of PathologyCaja Nacional de SaludLa PazBolivia
  4. 4.Department of PathologyAlbany Medical CollegeAlbanyUSA

Personalised recommendations